# A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy

> **NCT01084174** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 21 (actual)

## Conditions studied

- Peanut Hypersensitivity
- Food Hypersensitivity
- Immediate Hypersensitivity

## Interventions

- **DRUG:** Peanut powder
- **DRUG:** Peanut extract
- **DRUG:** Placebo extract
- **DRUG:** Placebo powder

## Key facts

- **NCT ID:** NCT01084174
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-01
- **Final completion:** 2013-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084174, "A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01084174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*